Molecular footprints of neurotoxic amphetamine action

Annals of the New York Academy of Sciences

Volumn 914, Issue , 2000, Pages 92-103

  Kuhn, Donald M ^a,b   Geddes, Timothy J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 2125 Scott Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CATECHOL; DOPAMINE; METHAMPHETAMINE; NITRIC OXIDE; NITROGEN; NUCLEOTIDE DERIVATIVE; PEROXYNITRITE; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; NEUROTOXICITY; OXIDATIVE STRESS; PROTEIN MODIFICATION; PROTEIN TARGETING; REDUCTION; SEROTONINERGIC NERVE CELL; TOXICOKINETICS;

EID: 0033710752     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05187.x     Document Type: Article

References (57)

1. Neurotoxicity, drugs and abuse, and the CuZn-superoxide dismutase transgenic mice
2. Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: Evidence from the use of CuZnSOD transgenic mice
3. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)
4. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice
5. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice
6. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity
7. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo
8. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine
9. Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats
10. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum
11. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain
12. MDMA: Historical perspectives
13. Neurochemical basis of neurotoxicity
14. Neurotoxicity of amphetamines and their metabolites
15. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: Possible endogenous toxin to serotonin neurons
16. Inactivation of tryptophan hydroxylase by nitric oxide: Enhancement by tetrahydrobiopterin
17. Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: Attack on critical sulfhydryls that spare the enzyme iron center
18. Inactivation of brain tryptophan hydroxylase by nitric oxide
19. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
20. In vivo detection of short- and long-term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain
21. 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Pharmacology and toxicology in animals and humans
22. Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings
23. Rapid and reversible effects of methamphetamine on dopamine transporters
24. A rapid and reversible change in dopamine transporters induced by methamphetamine
25. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
26. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: Oxidative consequences?
27. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function
28. The reaction of NO with superoxide
29. Oxidative chemistry of peroxynitrite
30. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
31. Expression and deletion mutagenesis of tryptophan hydroxylase fusion proteins: Delineation of the enzyme catalytic core
32. Modification of the tyrosine hydroxylase assay: Increased enzyme activity in the presence of ascorbic acid
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
34. Tissue sulfhydryl groups
35. Detection and quantitation of nitrotyrosine residues in proteins: In vivo marker of peroxynitrite
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
37. Antibodies that recognize nitrotyrosine
38. Covalent cross-links in a structural protein, resilin
39. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues
40. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite
41. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide
42. Tetranitromethane: A reagent for the nitration of tyrosyl residues in proteins
43. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide
44. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not
45. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine
46. Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase
47. Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: Comparison with tyrosine hydroxylase activity
48. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and non-protective agents
49. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems
50. Kinetics of peroxynitrite reaction with amino acids and human serum albumin
51. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
52. Protein nitration in Parkinson's disease
53. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
54. Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide
55. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
56. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
57. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)